Implantable cardioverter-defibrillator use for sudden cardiac death prevention. Experience of Burdenko Main Military Clinical Hospital

1. Л.А. Бокерия, А.Ш. Ревишвили, А.В. Ардашев, Д.З. Кочович. Желудочковые аритмии./ГВКГ им. Н.Н. Бурденко. М.: Медпрактика-М, 2002.

2. Zecchin M., Sinagra G. Primary prevention of sudden death in dilated cardiomyopathy. Italian Heart J. 2004; 5 Suppl. 1: 81S-82S.

3. Kannel W.B., Doyle J.T., McNamera, et al. Precursors of sudden coronary death: factors related to the incidence of sudden death. Circulation. 1975; 57: 606-13.

4. DiMarco J.P. Implantable Cardioverter-Defibrillators. N. Engl. J. Med. 2003; 349 (19): 1836-1847.

5. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID). Investigators. N. Engl. J. Med. 1997; 337: 1576-1583.

6. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: Multicenter Automatic Defibrillators Implantation Trial Investigators (MADIT I). N. Engl. J. Med. 1996; 335: 1933-1940.

7. Buxton A.E., Lee K.L., Fisher J.D., et al. A randomized study of the prevention of sudden death in patients with coronary artery diseases: Multicenter Unsustained Tachycardia Trial Investigators. N. Engl. J. Med. 1999; 341: 1882-2135.

8. Bigger J.Т. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary -artery graft surgery: Coronary Artery Bypass Graft (GABG) Patch trial Investigators. N. Engl. J. Med. 1997; 337: 1569-1575.

9. Moss A.J., Cannom D.S., Daubert J.P., et al. Multicenter Automatic Defibrillator Implantation Trial II (MADIT II); Design and clinical protocol. ANE 1999; 4: 83-91.

10. Bansch D., Antz M., Boczor S., et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy. The Cardiomyopathy Trial (CAT). Circulation 2002; 105: 1453.

11. Corrado D., Leoni L., Buja G., et al. Does implantable cardioverter -defibrillator therapy modify the natural history of arrhythmogenic right ventricular cardiomyopathy. Italian Heart J. 2004; 5 Suppl. 1: 72-75.

12. Myerburg R.J., Mitrani R., Interian A., et al. Interpretation of outcomes of antiarrhythmic clinical trials. Circulation 1998; 97: 1514-1521.

13. Winters S.L., Packer D.L., Marchlinski F.E., et al. Consensus statement on indications, guidelines for use, and recommendations for follow-up of implantable cardioverter defibrillators.//J. Cardiovasc. Electrophysiol. 2002. Vol. 24, N 2.